Gianpaolo Reboldi Selected Research

Potassium

3/2024	Managing hyperkalemia in patients with heart failure on guideline-directed medical therapy: challenges and opportunities.
1/2017	How important is to reduce sodium and increase potassium in patients with hypertension?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianpaolo Reboldi Research Topics

Disease

26	Hypertension (High Blood Pressure) 01/2024 - 02/2006
12	Stroke (Strokes) 09/2023 - 08/2005
11	Atrial Fibrillation 10/2023 - 01/2014
10	Heart Failure 03/2024 - 05/2010
8	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 01/2004
8	COVID-19 01/2023 - 01/2020
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 04/2010
5	Diabetic Nephropathies (Diabetic Nephropathy) 04/2024 - 05/2010
5	Hemorrhage 04/2021 - 01/2015
5	Diabetes Mellitus 05/2017 - 11/2009
5	Hypertrophy 03/2015 - 01/2004
5	Myocardial Infarction 08/2012 - 07/2008
5	Type 2 Diabetes Mellitus (MODY) 07/2012 - 01/2009
4	Chronic Renal Insufficiency 01/2024 - 04/2011
4	Infarction (Infarctions) 12/2015 - 01/2010
3	Hyperglycemia 01/2024 - 01/2015
3	Acute Coronary Syndrome 09/2023 - 03/2012
3	Infections 07/2021 - 01/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 04/2011
3	Thromboembolism 01/2018 - 01/2014
3	Proteinuria 02/2012 - 01/2009
2	Insulin Resistance 03/2024 - 12/2015
2	Hypotension (Low Blood Pressure) 01/2024 - 04/2023
2	Hyperuricemia 09/2023 - 01/2023
2	Neoplasms (Cancer) 04/2021 - 05/2003
2	Inflammation (Inflammations) 05/2020 - 12/2015
2	Albuminuria 02/2020 - 11/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 11/2010
2	Systolic Heart Failure 12/2016 - 12/2016
2	Embolism (Embolus) 01/2015 - 01/2014
2	Essential Hypertension 01/2004 - 03/2002
1	Hyperkalemia 03/2024
1	Fibrosis (Cirrhosis) 01/2024
1	Hypoxia (Hypoxemia) 01/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2023
1	Kidney Diseases (Kidney Disease) 09/2023
1	Acute Kidney Injury (Acute Renal Failure) 04/2023
1	Autoimmune Diseases (Autoimmune Disease) 03/2023
1	Chylous Ascites 03/2023
1	Retroperitoneal Fibrosis 03/2023
1	Metabolic Diseases (Metabolic Disease) 02/2023
1	Hypertriglyceridemia 02/2023
1	Ventricular Remodeling 01/2023

Drug/Important Bio-Agent (IBA)

12	Angiotensin Receptor AntagonistsIBA 10/2020 - 07/2008
12	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 08/2005
8	AnticoagulantsIBA 10/2023 - 02/2014
7	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 02/2006
7	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 03/2023 - 08/2005
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2009
6	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 02/2006
6	aliskiren FDA Link 01/2014 - 01/2008
5	Uric Acid (Urate)IBA 01/2024 - 02/2021
5	DiureticsIBA 02/2022 - 08/2005
5	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 01/2014
4	HDL CholesterolIBA 01/2024 - 02/2006
4	Dabigatran FDA Link 01/2018 - 01/2014
4	CholesterolIBA 05/2017 - 01/2004
3	Triglycerides (Triacylglycerol)IBA 03/2024 - 03/2015
3	SodiumIBA 01/2024 - 01/2017
3	CreatinineIBA 01/2023 - 04/2010
3	VaccinesIBA 05/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
3	Angiotensin IIIBA 01/2022 - 01/2008
3	Insulin (Novolin)FDA Link 02/2020 - 01/2015
3	Vitamin K FDA Link 01/2018 - 01/2015
3	Ramipril (Altace)FDA LinkGeneric 01/2015 - 06/2010
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2014 - 04/2011
2	PotassiumIBA 03/2024 - 01/2017
2	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 01/2024
2	ElectrolytesIBA 01/2024 - 04/2023
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2024 - 01/2023
2	Celecoxib (Celebrex)FDA Link 11/2018 - 08/2010
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2016 - 08/2011
2	Natriuretic PeptidesIBA 12/2016 - 12/2016
2	N(4)-oleylcytosine arabinosideIBA 04/2016 - 01/2014
2	CatecholaminesIBA 12/2015 - 01/2015
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2015 - 01/2015
2	edoxabanIBA 01/2015 - 01/2014
2	apixabanIBA 01/2015 - 01/2014
2	Telmisartan (Micardis)FDA Link 01/2015 - 03/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012 - 03/2012
1	sodium zirconium cyclosilicateIBA 03/2024
1	patiromerIBA 03/2024
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024
1	Neprilysin (Neutral Endopeptidase)IBA 03/2024
1	Sodium-Glucose Transport ProteinsIBA 03/2024
1	LipidsIBA 01/2024
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2024
1	MineralocorticoidsIBA 01/2024
1	ElementsIBA 09/2023
1	CalciumIBA 03/2023
1	AngiotensinsIBA 01/2023
1	alpha-Tocopherol FDA Link 05/2022
1	Vitamin E FDA LinkGeneric 05/2022

Therapy/Procedure

16	Therapeutics 04/2024 - 03/2002
2	Drug Therapy (Chemotherapy) 02/2022 - 07/2009
2	Catheter Ablation 04/2021 - 01/2018
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 01/2018
1	Transcutaneous Electric Nerve Stimulation (TENS) 03/2024
1	Peritoneal Dialysis 03/2023